Military service exposes personnel to environmental hazards that can have long-term impacts on lung health. Dust, smoke from burn pits, chemical agents, and high-intensity physical activity increase the risk of chronic respiratory disorders among veterans. Symptoms such as persistent cough, wheezing, shortness of breath, and reduced exercise tolerance often appear months or years after service, making diagnosis challenging. Evaluating these individuals requires detailed exposure histories, pulmonary function testing, imaging studies, and sometimes bronchoscopy to detect subtle airway inflammation or fibrotic changes. Early identification of military service–related lung disease is critical to prevent progression and reduce long-term complications, and preventive measures such as protective equipment and exposure monitoring can help mitigate risks during active duty.
Long-term care focuses on improving lung function, reducing symptoms, and preventing further deterioration. Pharmacologic therapies may include anti-inflammatory medications and bronchodilators tailored to individual patient needs. Pulmonary rehabilitation programs, physical conditioning, and lifestyle modifications such as smoking cessation are essential components of ongoing care. Structured follow-up enables early recognition of exacerbations and timely intervention, while multidisciplinary collaboration between pulmonologists, rehabilitation specialists, and veteran healthcare services ensures comprehensive support. Research into deployment-related exposures continues to inform clinical practice, preventive policies, and veteran health programs. Together, these strategies help optimize respiratory outcomes, support functional capacity, and enhance quality of life for affected military personnel.
Title : Novel signaling mechanisms and innovative therapeutic strategies of pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Susceptibility to SARS-CoV-2 infection and nasal air conditioning ability
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Comparative evaluation of DECAF and BAP 65 scores in predicting outcomes of COPD exacerbations among in patients at Vicente Sotto Memorial Medical Center
Allanys Joy Q Pino, Vicente Sotto Memorial Medical Center, Philippines
Title :
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States
Title : Personalized and precision Medicine (PPM) as a unique healthcare model through biodesign driven and inspired biotech, translational applications and pulmonology related marketing to secure the human healthcare, wellness and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation